Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

N. R. Sluiter, E. M. V. de Cuba, R. Kwakman, W. J. H. J. Meijerink, P. M. Delis-van Diemen, V. M. H. Coupe, J. A. M. Belien, G. A. Meijer, I. H. J. T. de Hingh, E. A. te Velde

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)297-307
JournalClinical & experimental metastasis
Issue number4
Publication statusPublished - Apr 2016


  • Angiogenesis
  • Biomarkers
  • Colorectal cancer
  • Peritoneal metastases
  • VEGF
  • Versican

Cite this